Carmila: Withdrawal of funds for the liquidity contract
08 Maio 2024 - 12:45PM
Business Wire
Regulatory News:
On November 3rd, 2023, Carmila SA (Paris:CARM) (ISIN:
FR0010828137) has entered into a Liquidity Contract with Kepler
Cheuvreux (the "Contract"). This Contract, with an initial
amount of 971 454,65 Euros and 124 528 number of Shares, aims to
promote the liquidity of the Shares of Carmila SA on the regulated
market of Euronext Paris.
In order to adjust the amount available for this Contract, on 7
May 2024 a withdrawal of 78 000 Shares from the Liquidity Account
(the "Withdrawal") has been carried out.
The Withdrawal has been executed in accordance with the legal
provisions in force, and more specifically with the provisions of
Regulation (EU) No. 596/2014 of the European Parliament and of the
Council of 16 April 2014 on market abuse (MAR), the delegated
Commission Regulation (EU) 2016/908 of 26 February 2016
supplementing Regulation (EU) No 596/2014 of the European
Parliament and of the Council with regulatory technical standards
concerning the criteria, procedure and requirements for
establishing an accepted market practice and the requirements for
maintaining, withdrawing or amending the conditions for admission,
and Articles L. 225-209 et seq. of the French Commercial Code, and
the AMF decision no. 2021-01 of June 22, 2021, applicable as of
July 1, 2021.
INVESTOR AGENDA
24 July 2024 (after market close): First half 2024
results 25 July 2024: First half 2024 results presentation
17 October 2024 (after market close): Financial information
for the third quarter 2024
ABOUT CARMILA
As the third-largest listed owner of commercial property in
Europe, Carmila was founded by Carrefour and large institutional
investors in order to enhance the value of shopping centres
adjoining Carrefour hypermarkets in France, Spain and Italy. At 31
December 2023, its portfolio was valued at €5.9 billion and is made
up of 201 shopping centres, with leading positions in their
catchment areas.
Carmila is listed on Euronext-Paris Compartment A under the
symbol CARM. It benefits from the tax regime for French real estate
investment trusts (“SIIC”). Carmila has been a member of the SBF
120 since 20 June 2022.
Important notice
Some of the statements contained in this document are not
historical facts but rather statements of future expectations,
estimates and other forward-looking statements based on
management’s beliefs. These statements reflect such views and
assumptions prevailing as of the date of the statements and involve
known and unknown risks and uncertainties that could cause future
results, performance or events to differ materially from those
expressed or implied in such statements. Please refer to the most
recent Universal Registration Document filed in French by Carmila
with the Autorité des marchés financiers for additional information
in relation to such factors, risks and uncertainties. Carmila has
no intention and is under no obligation to update or review the
forward-looking statements referred to above. Consequently, Carmila
accepts no liability for any consequences arising from the use of
any of the above statements.
This press release is available in the
“Regulatory Information” section of Carmila’s Finance webpage:
https://www.carmila.com/en/finance/regulatory-information/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240508041624/en/
INVESTOR AND ANALYST CONTACT Jonathan Kirk – Head of Investor
Relations jonathan_kirk@carmila.com +33 6 31 71 83 98
PRESS CONTACT Elodie Arcayna – Corporate Communications Director
elodie_arcayna@carmila.com +33 7 86 54 40 10
Carisma Therapeutics (NASDAQ:CARM)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Carisma Therapeutics (NASDAQ:CARM)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024